ARENA PHARMACEUTICALS INC - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO AND CFO - March 16, 2010

Attached files

file filename
10-K - FORM 10-K - ARENA PHARMACEUTICALS INCd10k.htm
EX-31.1 - CERTIFICATION OF CEO - ARENA PHARMACEUTICALS INCdex311.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ARENA PHARMACEUTICALS INCdex211.htm
EX-31.2 - CERTIFICATION OF CFO - ARENA PHARMACEUTICALS INCdex312.htm
EX-10.36 - AMENDMENT #2 TO TOLL MANUFACTURING AGREEMENT - ARENA PHARMACEUTICALS INCdex1036.htm
EX-10.51 - SUMMARY OF COMPENSATION FOR NON-EMPLOYEE DIRECTORS - ARENA PHARMACEUTICALS INCdex1051.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ARENA PHARMACEUTICALS INCdex231.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Arena Pharmaceuticals, Inc. (“Arena”) for the period ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Jack Lief, as President and Chief Executive Officer of Arena, and Robert E. Hoffman, as Vice President, Finance and Chief Financial Officer of Arena, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Arena.

 

/S/    JACK LIEF        

Jack Lief

    

/S/    ROBERT E. HOFFMAN        

Robert E. Hoffman

President and Chief Executive Officer    

Vice President, Finance and Chief Financial

Officer

Date: March 16, 2010

     Date: March 16, 2010

ARENA PHARMACEUTICALS INC Reports